This content is machine translated Diabetes mellitus type 2 New Swiss guidelines support cardiovascular disease control The treatment of type 2 diabetes mellitus has undergone a transformation in recent years with the approval of new drug classes. The focus is no longer on pure glycemic control,…
View Post 5 min This content is machine translated Chronic coronary syndrome Risk stratification in coronary artery disease – an update. Coronary CT is highly ranked for the work-up algorithm in the updated European Society of Cardiology (ESC) guidelines. Calcification is an important prognostic indicator and has therapeutic implications. Among other…
View Post 6 min This content is machine translated COPD therapy Biomarkers could facilitate many things 22-40% of all COPD patients experience at least one moderate or severe exacerbation annually. Patients with frequent exacerbations have a worse prognosis. A team of researchers has been looking at…
View Post 4 min This content is machine translated COVID-19 and cardiovascular disease. Current findings and expert cardiological opinion on ACE inhibitors and ARBs. There is some uncertainty among patients and experts as to whether ACE inhibitors and ARBs are associated with an increased risk. Empirical data on this are inconsistent, but there are…
View Post 3 min This content is machine translated Heart failure in type 2 diabetes Indication expansion for SGLT2 inhibitor and combination preparation Because of the high prevalence and mortality, it is particularly important to protect patients with type 2 diabetes from heart failure as early as possible. The indication expansion of dapagliflozin…
View Post 11 min This content is machine translated Hypertension in practice High blood pressure – What the family doctor needs to know After a confirmed diagnosis of arterial hypertension, one should assess the severity, overall cardiovascular risk, and any organ damage present. First-line antihypertensives are RAAS blockers alone or combined with Ca…
View Post 7 min This content is machine translated "The lower the better" New AGLA Pocket Guide “Prevention of Atherosclerosis To reduce the risk of cardiovascular disease, low LDL-C levels are critical [1]. This finding is also reflected in the ESC/EAS Dyslipidemia Guidelines – the basis for the new Swiss…
View Post 11 min This content is machine translated SVT Narrow complex tachycardia – differential diagnosis and management. Narrow complex tachycardia is a common clinical presentation. Reentry, in particular, provides persistent tachycardia. The prerequisite for the development of reentry tachycardia is a substrate with two distinct conduction pathways…
View Post 8 min This content is machine translated Acute heart failure Diagnostics and initial stabilization Acute heart failure is a life-threatening situation that requires rapid and planned action. How does the clarification take place? What therapeutic measures are available? A look at initial stabilization in…
View Post 4 min This content is machine translated Cardiovascular risk management Treatment of hypertensive patients with dyslipidemia – an update. Target values for blood pressure and LDL have become more stringent in recent years, so extended risk stratification may make sense. Hypertension and dyslipidemia are among the most important cardiovascular…
View Post 15 min This content is machine translated Chronic Thromboembolic Pulmonary Hypertension Diagnostics and therapy of CTEPH Chronic thromboembolic pulmonary hypertension (CTEPH) is a subtype of pulmonary hypertension (PH). The diagnosis is overall very rare, although CTEPH is also often unrecognized and thus underdiagnosed, and therefore the…
